{"DataElement":{"publicId":"7976980","version":"1","preferredName":"SARS Coronavirus 2 Genome Variation Present Type","preferredDefinition":"Variants caused by gene mutations of SARS-CoV-2.","longName":"SARS_COV_GENE_VAR_NM","context":"NIH","contextVersion":"1","DataElementConcept":{"publicId":"7976976","version":"1","preferredName":"SARS Coronavirus 2 Genome Variation Present","preferredDefinition":"A positive-sense single-stranded RNA virus in the genus Betacoronavirus. It is the causative agent of the 2019-2020 severe acute respiratory syndrome outbreak._All of the differences in the complete genomic sequence of an organism when compared to a reference sequence._Being or existing in a specified place or at the specified time.","longName":"7976974v1.0:2233878v1.0","context":"NIH","contextVersion":"1","ObjectClass":{"publicId":"7976974","version":"1","preferredName":"SARS Coronavirus 2 Genome Variation","preferredDefinition":"A positive-sense single-stranded RNA virus in the genus Betacoronavirus. It is the causative agent of the 2019-2020 severe acute respiratory syndrome outbreak.:All of the differences in the complete genomic sequence of an organism when compared to a reference sequence.","longName":"C169076:C179559","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SARS Coronavirus 2","conceptCode":"C169076","definition":"A positive-sense single-stranded RNA virus in the genus Betacoronavirus. It is the causative agent of the 2019-2020 severe acute respiratory syndrome outbreak.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Genome Variation","conceptCode":"C179559","definition":"All of the differences in the complete genomic sequence of an organism when compared to a reference sequence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D30B59A3-76BA-254E-E053-4EBD850AD2FB","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233878","version":"1","preferredName":"Present","preferredDefinition":"Being or existing in a specified place or at the specified time.","longName":"C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F970CDF6-F829-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435027","version":"1","preferredName":"Gene","preferredDefinition":"A functional unit of heredity which occupies a specific position (locus) on a particular chromosome, is capable of reproducing itself exactly at each cell division, and directs the formation of a protein or other product. The gene as a functional unit consists of a discrete segment of a giant DNA molecule containing the purine (adenine and guanine) and pyrimidine (cytosine and thymine) bases in the ordered and correct sequence that encodes a specific functional product (i.e., a protein or RNA molecule).","longName":"C16612","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07431EBC-FB05-25D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D30B59A3-76C8-254E-E053-4EBD850AD2FB","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"KUMMEROA","dateModified":"2022-02-16","changeDescription":"2022-2-16 ak Released per DW review. 2021-2-13 ak Created for Project 5 Tier 1.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7976978","version":"1","preferredName":"SARS Coronavirus 2 Genome Variation Name","preferredDefinition":"A positive-sense single-stranded RNA virus in the genus Betacoronavirus. It is the causative agent of the 2019-2020 severe acute respiratory syndrome outbreak._All of the differences in the complete genomic sequence of an organism when compared to a reference sequence._Something distinguishable as an identifiable class based on common qualities._The words or language units by which a thing is known.","longName":"SARS_COV_GENO_VAR_NM","context":"NIH","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"35","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other, Specify","valueDescription":"If Other, Specify","ValueMeaning":{"publicId":"7557010","version":"1","preferredName":"If Other, Specify","longName":"7557010","preferredDefinition":"A directive to specify when the listed responses are not sufficient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"If Other, Specify","conceptCode":"C157101","definition":"A directive to specify when the listed responses are not sufficient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9D26A12-EF66-4B33-E053-4EBD850ACC4C","latestVersionIndicator":"Yes","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-26","modifiedBy":"CLOHNES","dateModified":"2022-06-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D30B93BD-3E1F-311A-E053-4EBD850A57C5","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","deletedIndicator":"No"},{"value":"B.1.128 Brazil","valueDescription":"SARS Coronavirus 2 B.1.128","ValueMeaning":{"publicId":"7976986","version":"1","preferredName":"SARS Coronavirus 2 B.1.128","longName":"7976986","preferredDefinition":"A variant lineage of SARS coronavirus 2 that is the ancestor for the P.1 and P.2 lineages.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SARS Coronavirus 2 B.1.128","conceptCode":"C179600","definition":"A variant lineage of SARS coronavirus 2 that is the ancestor for the P.1 and P.2 lineages.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D30B93BD-3E2C-311A-E053-4EBD850A57C5","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D30B93BD-3E45-311A-E053-4EBD850A57C5","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","deletedIndicator":"No"},{"value":"P.1 Japan/Brazil","valueDescription":"SARS Coronavirus 2 P.1","ValueMeaning":{"publicId":"7976987","version":"1","preferredName":"SARS Coronavirus 2 P.1","longName":"7976987","preferredDefinition":"A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: amino acid substitutions L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I and V1176F.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SARS Coronavirus 2 P.1","conceptCode":"C179599","definition":"A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: amino acid substitutions L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I and V1176F.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D30B93BD-3E51-311A-E053-4EBD850A57C5","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D30B93BD-3E6A-311A-E053-4EBD850A57C5","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","deletedIndicator":"No"},{"value":"P.2 Brazil April 2020","valueDescription":"SARS Coronavirus 2 P.2","ValueMeaning":{"publicId":"7976988","version":"1","preferredName":"SARS Coronavirus 2 P.2","longName":"7976988","preferredDefinition":"A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: amino acid substitutions E484K, D614G and V1176F. The substitution F565L has also been detected in some but not all sequences for this lineage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SARS Coronavirus 2 P.2","conceptCode":"C179598","definition":"A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: amino acid substitutions E484K, D614G and V1176F. The substitution F565L has also been detected in some but not all sequences for this lineage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D30B93BD-3E76-311A-E053-4EBD850A57C5","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D30B93BD-3E8F-311A-E053-4EBD850A57C5","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","deletedIndicator":"No"},{"value":"B.1.617.3 India October 2020","valueDescription":"SARS Coronavirus 2 B.1.617.3","ValueMeaning":{"publicId":"7976989","version":"1","preferredName":"SARS Coronavirus 2 B.1.617.3","longName":"7976989","preferredDefinition":"A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: amino acid substitutions T19R, G142D, L452R, E484Q, D614G, P681R, D950N.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SARS Coronavirus 2 B.1.617.3","conceptCode":"C179596","definition":"A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: amino acid substitutions T19R, G142D, L452R, E484Q, D614G, P681R, D950N.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D30B93BD-3E9B-311A-E053-4EBD850A57C5","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D30B93BD-3EB4-311A-E053-4EBD850A57C5","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","deletedIndicator":"No"},{"value":"B.1.617.2 India December 2020","valueDescription":"SARS Coronavirus 2 B.1.617.2","ValueMeaning":{"publicId":"7976990","version":"1","preferredName":"SARS Coronavirus 2 B.1.617.2","longName":"7976990","preferredDefinition":"A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 156 and 157 and amino acid substitutions T19R, R158G, L452R, T478K, D614G, P681R and D950N. The substitution G142D has also been detected in some but not all sequences for this lineage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SARS Coronavirus 2 B.1.617.2","conceptCode":"C179586","definition":"A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 156 and 157 and amino acid substitutions T19R, R158G, L452R, T478K, D614G, P681R and D950N. The substitution G142D has also been detected in some but not all sequences for this lineage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D30B93BD-3EC0-311A-E053-4EBD850A57C5","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D30B93BD-3ED9-311A-E053-4EBD850A57C5","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","deletedIndicator":"No"},{"value":"B.1.617.1 India December 2020","valueDescription":"SARS Coronavirus 2 B.1.617.1","ValueMeaning":{"publicId":"7976991","version":"1","preferredName":"SARS Coronavirus 2 B.1.617.1","longName":"7976991","preferredDefinition":"A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: amino acid substitutions G142D, E154K, L452R, E484Q, D614G, P681R and Q1071H. The substitution T95I has also been detected in some but not all sequences for this lineage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SARS Coronavirus 2 B.1.617.1","conceptCode":"C179585","definition":"A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: amino acid substitutions G142D, E154K, L452R, E484Q, D614G, P681R and Q1071H. The substitution T95I has also been detected in some but not all sequences for this lineage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D30B93BD-3EE5-311A-E053-4EBD850A57C5","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D30B93BD-3EFE-311A-E053-4EBD850A57C5","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","deletedIndicator":"No"},{"value":"B.1.617 India February 2021","valueDescription":"SARS Coronavirus 2 B.1.617","ValueMeaning":{"publicId":"7976992","version":"1","preferredName":"SARS Coronavirus 2 B.1.617","longName":"7976992","preferredDefinition":"A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: amino acid substitutions L452R, E484Q and D614G.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SARS Coronavirus 2 B.1.617","conceptCode":"C179583","definition":"A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: amino acid substitutions L452R, E484Q and D614G.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D30B93BD-3F0A-311A-E053-4EBD850A57C5","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D30B93BD-3F23-311A-E053-4EBD850A57C5","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","deletedIndicator":"No"},{"value":"B.1.526.1 US New York October 2020","valueDescription":"SARS Coronavirus 2 B.1.526.1","ValueMeaning":{"publicId":"7976993","version":"1","preferredName":"SARS Coronavirus 2 B.1.526.1","longName":"7976993","preferredDefinition":"A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletion of the amino acids at position 144 and amino acid substitutions D80G, F157S, L452R, D614G and D950H. The substitutions T791I and T859N have also been detected in some but not all sequences for this lineage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SARS Coronavirus 2 B.1.526.1","conceptCode":"C179582","definition":"A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletion of the amino acids at position 144 and amino acid substitutions D80G, F157S, L452R, D614G and D950H. The substitutions T791I and T859N have also been detected in some but not all sequences for this lineage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D30B93BD-3F2F-311A-E053-4EBD850A57C5","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D30B93BD-3F48-311A-E053-4EBD850A57C5","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","deletedIndicator":"No"},{"value":"B.1.526 US New Your November 2020","valueDescription":"SARS Coronavirus 2 B.1.526","ValueMeaning":{"publicId":"7976994","version":"1","preferredName":"SARS Coronavirus 2 B.1.526","longName":"7976994","preferredDefinition":"A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: amino acid substitutions T95I, D253G and D614G. The substitutions L5F, S477N, E484K and A701V have also been detected in some but not all sequences for this lineage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SARS Coronavirus 2 B.1.526","conceptCode":"C179580","definition":"A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: amino acid substitutions T95I, D253G and D614G. The substitutions L5F, S477N, E484K and A701V have also been detected in some but not all sequences for this lineage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D30B93BD-3F54-311A-E053-4EBD850A57C5","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D30B93BD-3F6D-311A-E053-4EBD850A57C5","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","deletedIndicator":"No"},{"value":"B.1.525 UK/Nigeria December 2020","valueDescription":"SARS Coronavirus 2 B.1.525","ValueMeaning":{"publicId":"7976995","version":"1","preferredName":"SARS Coronavirus 2 B.1.525","longName":"7976995","preferredDefinition":"A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 69, 70 and 144 and amino acid substitutions A67V, E484K, D614G, Q677H and F888L.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SARS Coronavirus 2 B.1.525","conceptCode":"C179579","definition":"A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 69, 70 and 144 and amino acid substitutions A67V, E484K, D614G, Q677H and F888L.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D30B93BD-3F79-311A-E053-4EBD850A57C5","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D30B93BD-3F92-311A-E053-4EBD850A57C5","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","deletedIndicator":"No"},{"value":"B.1.429 US California","valueDescription":"SARS Coronavirus 2 B.1.429","ValueMeaning":{"publicId":"7976996","version":"1","preferredName":"SARS Coronavirus 2 B.1.429","longName":"7976996","preferredDefinition":"A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: amino acid substitutions S13I, W152C, L452R and D614G.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SARS Coronavirus 2 B.1.429","conceptCode":"C179577","definition":"A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: amino acid substitutions S13I, W152C, L452R and D614G.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D30B93BD-3F9E-311A-E053-4EBD850A57C5","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D30B93BD-3FB7-311A-E053-4EBD850A57C5","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","deletedIndicator":"No"},{"value":"B.1.427 US California","valueDescription":"SARS Coronavirus 2 B.1.427","ValueMeaning":{"publicId":"7976997","version":"1","preferredName":"SARS Coronavirus 2 B.1.427","longName":"7976997","preferredDefinition":"A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: amino acid substitutions L452R and D614G.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SARS Coronavirus 2 B.1.427","conceptCode":"C179576","definition":"A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: amino acid substitutions L452R and D614G.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D30B93BD-3FC3-311A-E053-4EBD850A57C5","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D30B93BD-3FDC-311A-E053-4EBD850A57C5","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","deletedIndicator":"No"},{"value":"B.1.351 South Africa","valueDescription":"SARS Coronavirus 2 B.1.351","ValueMeaning":{"publicId":"7976998","version":"1","preferredName":"SARS Coronavirus 2 B.1.351","longName":"7976998","preferredDefinition":"A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 241-242 and amino acid substitutions D80A, D215G, K417N, E484K, N501Y, D614G and A701V.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SARS Coronavirus 2 B.1.351","conceptCode":"C179575","definition":"A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 241-242 and amino acid substitutions D80A, D215G, K417N, E484K, N501Y, D614G and A701V.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D30B93BD-3FE8-311A-E053-4EBD850A57C5","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D30B93BD-4001-311A-E053-4EBD850A57C5","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","deletedIndicator":"No"},{"value":"B.1.1.7 UK","valueDescription":"SARS Coronavirus 2 B.1.1.7","ValueMeaning":{"publicId":"7976979","version":"1","preferredName":"SARS Coronavirus 2 B.1.1.7","longName":"7976979","preferredDefinition":"A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 69, 70 and 144 and amino acid substitutions N501Y, A570D, D614G, P681H, T716I, S982A and D1118H. The substitutions E484K, S494P and K1191N have also been detected in some but not all sequences for this lineage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SARS Coronavirus 2 B.1.1.7","conceptCode":"C179573","definition":"A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 69, 70 and 144 and amino acid substitutions N501Y, A570D, D614G, P681H, T716I, S982A and D1118H. The substitutions E484K, S494P and K1191N have also been detected in some but not all sequences for this lineage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D3071F7A-F807-4DDA-E053-4EBD850A34F4","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D3071F7A-F820-4DDA-E053-4EBD850A34F4","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435027","version":"1","preferredName":"Gene","preferredDefinition":"A functional unit of heredity which occupies a specific position (locus) on a particular chromosome, is capable of reproducing itself exactly at each cell division, and directs the formation of a protein or other product. The gene as a functional unit consists of a discrete segment of a giant DNA molecule containing the purine (adenine and guanine) and pyrimidine (cytosine and thymine) bases in the ordered and correct sequence that encodes a specific functional product (i.e., a protein or RNA molecule).","longName":"C16612","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07431EBC-FB05-25D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7977009","version":"1","preferredName":"SARS Coronavirus 2 Genome Variation Name","preferredDefinition":"A positive-sense single-stranded RNA virus in the genus Betacoronavirus. It is the causative agent of the 2019-2020 severe acute respiratory syndrome outbreak.:All of the differences in the complete genomic sequence of an organism when compared to a reference sequence.:The words or language units by which a thing is known.","longName":"C169076:C179559:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SARS Coronavirus 2","conceptCode":"C169076","definition":"A positive-sense single-stranded RNA virus in the genus Betacoronavirus. It is the causative agent of the 2019-2020 severe acute respiratory syndrome outbreak.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Genome Variation","conceptCode":"C179559","definition":"All of the differences in the complete genomic sequence of an organism when compared to a reference sequence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D30A3EB4-C990-4416-E053-4EBD850A253D","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D3071F7A-F7EE-4DDA-E053-4EBD850A34F4","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"KUMMEROA","dateModified":"2022-02-16","changeDescription":"2022-2-16 ak Released per DW review. 2021-12-13 ak Created for Project 5 Tier 1.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"7244861","version":"1","longName":"COVID-19","context":"NCIP","ClassificationSchemeItems":[{"publicId":"8038915","version":"1","longName":"NIH","context":"NCIP"},{"publicId":"8038916","version":"1","longName":"Project 5 CDEs","context":"NCIP"}]},{"publicId":"7977821","version":"1","longName":"Project 5 COVID","context":"NIH","ClassificationSchemeItems":[{"publicId":"7977823","version":"1","longName":"Tier 1","context":"NIH"}]}],"AlternateNames":[{"name":"SARS-CoV-2 Genome Variant Name","type":"NIH COVID","context":"NIH"}],"ReferenceDocuments":[{"name":"What genome variant was noted?","type":"Preferred Question Text","description":"What genome variant was noted?","url":null,"context":"NIH"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D30B74F2-6211-4950-E053-4EBD850A57D4","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"KUMMEROA","dateModified":"2022-02-16","changeDescription":"2022-2-16 ak Released per DW review. 20231-12-13 ak Created for Project 5 Tier 1.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}